Bets against consumer staples rise in December: Walgreens, Campbell among most shorted
Seeking Alpha News (Wed, 15-Jan 11:15 AM ET)
Has CL been a good buy before earnings?
Market Chameleon (Wed, 15-Jan 5:58 AM ET)
Wells Fargo’s Harvey: Investors could be driving pricing strategy in stocks
Seeking Alpha News (Mon, 13-Jan 3:44 PM ET)
Piper Sandler Reaffirms Their Buy Rating on Colgate-Palmolive (CL)
TipRanks (Mon, 13-Jan 9:55 AM ET)
Colgate Declares Regular Quarterly Dividend
Business Wire (Wed, 11-Dec 4:30 PM ET)
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
Business Wire (Tue, 19-Nov 9:30 AM ET)
Colgate Women's Games Officially Kicks off 49th Season with Return to Indoor Competition
Business Wire (Tue, 12-Nov 9:00 AM ET)
Colgate Announces 3rd Quarter 2024 Results
Business Wire (Fri, 25-Oct 6:55 AM ET)
Is CL stock going up before upcoming earnings? Let's turn to history for clues
Market Chameleon (Wed, 9-Oct 6:57 AM ET)
History Shows CL could rally into earnings
Market Chameleon (Wed, 10-Jul 6:16 AM ET)
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of January 15, 2025, CL stock price climbed to $87.86 with 3,920,128 million shares trading.
CL has a beta of 0.16, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.02 to the broad based SPY ETF.
CL has a market cap of $71.79 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.91 earnings per share. This beat revenue expectation by $33 million and exceeded earnings estimates by $.03.
In the last 3 years, CL traded as high as $109.30 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, SPY, IVV, XLP.
CL has underperformed the market in the last year with a price return of +11.0% while the SPY ETF gained +25.8%. CL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.3% and -3.4%, respectively, while the SPY returned +1.8% and +1.1%, respectively.
CL support price is $86.88 and resistance is $88.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.